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The prevalence of asthma and obesity is increasing worldwide, and obesity is a well-documented risk factor for asthma. Themechanisms
underlying this association and parallel time trends remain largely unknown but genetic factors may be involved. Here, we report on a
common ~0.45Mb genomic inversion at 16p11.2 that can be accurately genotyped via SNP array data. We show that the inversion allele
protects against the joint occurrence of asthma and obesity in five large independent studies (combined sample size of 317 cases and 543
controls drawn from a total of 5,809 samples; combined OR¼ 0.48, p¼ 5.53 106). Allele frequencies show remarkable worldwide pop-
ulation stratification, ranging from 10% in East Africa to 49% in Northern Europe, consistent with discordant and extreme genetic drifts
or adaptive selections after human migration out of Africa. Inversion alleles strongly correlate with expression levels of neighboring
genes, especially TUFM (p¼ 3.03 1040) that encodes a mitochondrial protein regulator of energy balance and inhibitor of type 1 inter-
feron, and other candidates for asthma (IL27) and obesity (APOB48R and SH2B1). Therefore, by affecting gene expression, the ~0.45 Mb
16p11.2 inversion provides a genetic basis for the joint susceptibility to asthma and obesity, with a population attributable risk of 39.7%.
Differential mitochondrial function and basal energy balance of inversion alleles might also underlie the potential selection signature
that led to their uneven distribution in world populations.Introduction
Epidemiological studies have shown that obese individuals
are more likely to develop asthma than nonobese subjects
and that asthma symptoms may improve after weight
reduction.1 Obese individuals with asthma tend to have
more severe symptoms with poorer response to glucocorti-
coid therapy. In addition, the epidemiological association
between asthma and obesity seems to be modulated by
gender and atopy,2,3 but the mechanisms underlying
obesity in asthma remain largely unknown. Proposals for
the joint occurrence of these two disorders include comor-
bidities such as gastresophageal reflux or sleep disordered
breathing and common pathogenic mechanisms such as
systemic inflammation, increased oxidative stress, or hor-
monal dysfunction.4,5 Genetic factors may also be
involved in the coexistence of asthma and obesity. The
best-fitting model of shared components of variance indi-
cated that about 8% of the genetic component of obesity is
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The AmeRecent candidate gene and genome-wide association
studies (GWASs) have discovered polymorphisms in the
16p11.2 chromosomal region that are associated with
obesity or body mass index (BMI)7,8 and also with asthma
phenotypes.9 A functional SNP in the gene coding for
the SH2B adaptor protein 1 (SH2B1 [MIM 608937]) is
involved in the signaling of leptin,10 a hormone impli-
cated in T cell immune response in addition to its major
role in the regulation of body weight.11 SNPs located in
the vicinity of the IL27 (interleukin 27 [MIM 608273])
locus have also been associated with susceptibility to
asthma in adults and children.9,12 Recurrent copy-number
variations in 16p11.2 such as the microdeletion and
reciprocal microduplication (0.6 Mb, Mb 29.5–30.1,
UCSC Genome Browser build hg18) are associated with
extreme BMI and neuro-behavioral disorders.13,14 Dele-
tions of the immediately distal region encompassing
SH2B1 (0.22 Mb, Mb 28.75–28.95, hg18) have also been
reported in early-onset obesity, as well as in developmental
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variant (maximum size estimate ~0.45Mb: 28.25–28.7Mb,
hg18) was originally described during chromosome
16 assembly, where EIFVar1 and EIFVar2 are the reference
noninverted (EIFVar1/NI) and the inverted (EIFVar2/I)
alleles, respectively.19 Although the experimental detec-
tion of chromosomal inversions located in complex
genomic regions is difficult, recently described methods
can infer non- or low-recurrent inversions for which
recombination between the inverted and noninverted
segments is suppressed in heterozygous carriers via SNP
genotype data.20–22 One such detectable inversions is the
~0.45 Mb 16p11.2 inversion.21
Here we used SNP microarray data to detect and geno-
type the ~0.45 Mb polymorphic inversion at 16p11.2 by
using two algorithms20,21 and validated genotype predic-
tions with allele-specific molecular assays. Association
studies in a discovery case-control study for asthma (n ¼
2,205) and four validation data sets (n ¼ 3,604) revealed
that the ~0.45 Mb 16p11.2 inversion provides a genetic
basis for the joint susceptibility to asthma and obesity in
European populations. We estimated the inversion pre-
valence in several world populations and compared the
differences with demographic data showing an uneven
distribution in world populations and suggesting either
extraordinary genetic drift or adaptive selection. Func-
tional impact of inversion alleles was analyzed in blood
cell transcriptomes in two independent data sets pointing
to candidate genes for this shared susceptibility.
Material and Methods
Subjects, Genotype, and Phenotype Data
We initially studied the Estonian Gene Expression Cohort, which
is composed of 1,000 randomly selected samples (mean age 375
16.6 years; 50% females) from a larger cohort of 53,000 samples of
the Estonian Genome Center Biobank, University of Tartu (EG-
CUT). DNA was genotyped with the Human370CNV array (Illu-
mina). Only samples with genotyping success rate above 95%
were used. Cryptic relatedness was tested with the PLINK v.1.07
software. Only one of each detected relative pairs (up to second
cousins) was randomly chosen for the subsequent analyses. Sam-
ple mix-ups were corrected by MixupMapper software.23
The 1,184 samples of the HapMap 3 panel had been genotyped
with two platforms: the Illumina Human1M SNP array (by the
Wellcome Trust Sanger Institute) and the Affymetrix SNP 6.0 (by
the Broad Institute).24 Data from the two platforms corresponding
to genome build 36 release 2 were merged and downloaded in
PLINK format from the website. Data from 1000 Genomes were
used to define genotypes in samples available for additional
experimental validation. We then used DNAs from a total of 71
HapMap 3 individuals (23 European [CEU], 24 Yoruba, and 24
Asian [16 Chinese and 8 Japanese]), all obtained from Coriell.
For association studies with asthma and obesity, the discovery
sample corresponded to the European Community Respiratory
Health Survey I (ECRHS-I).25 This data set represents a nested
asthma case-control sample from the cohort, including all subjects
with asthma at baseline or follow-up with DNA and a random
sample of controls (n ¼ 2,205). Genotyping had been conducted
with the Illumina Human 610 quad array at the French National362 The American Journal of Human Genetics 94, 361–372, March 6Genotyping Centre (CNG) in the frame of the European GABRIEL
consortium where quality control (QC) of genotyping was also
conducted.
Four additional studies were used for association validation: (1)
the population-based EGCUT data (n ¼ 1,217), (2) the Epidemio-
logical study on Genetics and Environment of Asthma (EGEA)26
(n ¼ 1,252), (3) the Genetic Epidemiology of Chronic Obstructive
Pulmonary Disease (COPD) cohort (n ¼ 472) (COPDGene, dbGaP
Study accession number phs000179.v3.p2), and (4) the Asthma
Clinical Research Network (ACRN) (n ¼ 663) from the National
Heart, Lung, and Blood Institute SNP Health Association Asthma
Resource Project (SHARP, dbGaP Study Accession number
phs000166.v2.p1); studies 3 and 4 were from the database of
Genotypes and Phenotypes (dbGAP)27.
All individuals selected in the discovery and validation studies
were of European descent and all the analyses were adjusted for
gender and principal components in order to address any possible
confusion resulting from population stratification. From EGCUT,
we considered a nested case-control study including adult individ-
uals diagnosed with asthma belonging to the larger population-
based cohort of 53,000 samples from Estonia. Controls were
randomly selected from the general population without asthma
diagnosis. DNA was genotyped as indicated above. EGEA com-
bines a case-control study and a family study of asthmatic cases,
but only adults were used for the present analysis (ageR 18 years
old). Genotyping was conducted in a similar manner as in the
ECRHS-I study, previously described. COPDGene is an adult
case-control to study COPD that includes information about
asthma and obesity (BMI). In order to eliminate possible confu-
sion, the analysis only considered asthmatic and control individ-
uals without COPD. Genotyping was performed with Illumina
HumanOmni1 Quad v1-0 B platform. ACRN is part of SHARP, a
study that provides a genome-wide analysis in adults and children
who have participated in National Heart, Lung, and Blood Insti-
tute’s clinical research trials on asthma. Because all individuals
included in the ACRN study were adult cases diagnosed with
asthma, controls were obtained from the COPDGene study,
assuming both studies had been carried out in populations with
similar European ancestry. Notably, inversion genotype fre-
quencies in the controls of the COPDGene study were almost
identical to those in the discovery sample (ECRHS-I). Genotyping
for the SHARP studies was performed with the Affymetrix 6.0
platform.
Asthma diagnosis was based on a positive response to the ques-
tion whether it had been ever diagnosed, and obesity corre-
sponded to a BMI R30 kg/m2. We used this sensitive definition
for asthma (perhaps not the most specific) in order to have the
lowest misclassification and less biased coefficients among
studies. This definition was common for all studies and previ-
ously used in the GWASs performed with these data.28 Most indi-
viduals in the studies designed for asthma (ECRHS-I, EGEA, and
ACRN) had a more specific diagnosis of current asthma at recruit-
ment: attack of asthma during the last 12 months and/or current
use of asthma medication. The total number of individuals
included was 5,809, all adults of both genders: 1,872 cases with
a diagnosis of asthma and 3,937 controls without asthma,
including 317 cases with asthma and obesity and 543 controls
with obesity and no asthma (Table S5 available online). All
studies included in this manuscript had been performed in accor-
dance with the ethical standards of the responsible committee on
human experimentation and with proper informed consent from
cases and controls., 2014
Inversion Classification and Detection
We applied two algorithms that perform inversion calling from
SNP data: inveRsion21 and Phase Free Inversion Detection
Operator (PFIDO).20 We selected a region of interest defined by
the interval between flanking blocks of segmental duplications
(28.24–28.73 Mb, hg18) and let inveRsion look for a signal in the
region of interest widen by 2 Mb, with a sliding window size of
0.39 Mb (~80% the inverted interval). For the CEU data we used
inveRsion on phased haplotype data21 but for all other cohorts
the inversion signal could be detected with unphased genotype
data. We selected the model for which the classification could
explain most of the variance in the multidimensional scaling
step of PFIDO. Here, we implemented a simple version of the
method, where the clustering step is performed with a K-means
algorithm by using multiple initial conditions. The final classifi-
cation of inveRsion and PFIDO were contrasted with a Cohen’s
kappa and with the variability explained by inveRsion’s classifica-
tion by the multidimensional scaling analysis of PFIDO. We also
computed linkage disequilibrium (LD) between the inversion
and the SNPs of the region. For the ECRHS-I and EGEA samples,
a total of 80 SNPs were analyzed, and for the EGCUT samples
132 SNPs were analyzed. Additional analyses searching for inde-
pendent association of single SNPs in the region with either the
asthma or BMI variables were also performed.Comparative Mapping, Sequence, and Coalescence
Analyses
In order to define the genomic architecture of the human genome
region with respect to other species, we used the UCSC Genome
Browser and compared the genomic structure, the relative gene
order and orientation of the homologous regions, and the breaks
of synteny between human, mouse, and other mammals. Com-
plete alignment of the reference noninverted (EIFVar1/NI) and
the inversion (EIFVar2/I) haplotypes was performed with the
EMBOSS Stretcher algorithm. All single-nucleotide and inser-
tion/deletion differences between both haplotypes were anno-
tated covering both the single-copy region between segmental
duplications (119 kb) and the flanking inverted repeats (134 kb).
Sequence coalescence estimates were performed on the assump-
tion of complete lack of recombination between both haplotypes
over the 119 kb single-copy interval located between the flanking
blocks of segmental duplications. The time to most recent com-
mon ancestor was calculatedwithMEGA5 by the Kimura 2-param-
eter method and evolutionary rate equality assessed with Tajima’s
relative rate test.29 Divergence times between NI and I haplotypes
were estimated with the formula T ¼ K/2R (where T is time, K the
Kimura 2-parameter, and R the average taxa substitution rate) with
chimpanzee as an out-group. Tominimizemisalignmentmistakes,
we used 14,770 bp of chimpanzee sequence within the interval
that pair with no gaps with the human sequence. These estimates
were computed assuming a mutation rate of 2.5 3 108.
We identified the genotypes at the representative SNPs on
strong LD with inversion haplotypes in the NI and I alleles. We
then used the UCSC Genome Browser to define the genotypes at
those representative loci in nonhuman primates, as well as in
Neanderthal, Denisova, and several representative individuals
from modern human populations.Indel Polymorphism Genotyping
Two indel differences identified between the EIFVar1/NI and
EIFVar2/I sequences were genotyped by PCR under standard con-The Ameditions. For the 27 bp indel within APOB48R (apolipoprotein B48
receptor [MIM 605220]) (293 bp insertion allele, 266 bp deletion
allele), we used the primers 50-CTGTCTGACTCCCAGCAGGT-30
and 50-AGGCCAGGGCAATTTTAGAT-30. For the intergenic 19 bp
indel (224 bp insertion allele, 205 bp deletion allele), the primers
were 50-TACCGCACTAGGCCAATCTT-30 and 50-GTGTTTCTCC
CTTGCCTGAG-30. PCR products were visualized by ethidium bro-
mide staining after electrophoresis on 2% agarose gels.Gene Expression and Gene Ontology Enrichment
Analyses
Transcriptomic data of RNA from lymphoblastoid cell lines of
CEU individuals generated through the project E-MTAB-198
were obtained from the European Bioinformatics Institute at
EMBL. Only data from 105 unrelated individuals were analyzed,
removing samples from family relatives. We also assessed the asso-
ciation between inversion and gene expression levels in RNA from
peripheral blood samples of the EGCUT sample. Whole-blood
RNA was collected with Tempus Blood RNA Tubes (Life Technolo-
gies), RNA was extracted with Tempus Spin RNA Isolation Kit
(Life Technologies), and quality was measured by NanoDrop
1000 Spectrophotometer (Thermo Fisher Scientific) and Agilent
2100 Bioanalyzer (Agilent Technologies). Whole-genome gene-
expression levels were obtained by Illumina HT12v3 arrays
(Illumina) according manufacturer’s protocols. Low-quality sam-
ples were excluded. All probes with primer polymorphisms were
left out, leaving 34,282 probes. Raw gene expression data was
Log-Quantile normalized withMixupMapper software.23 The final
EGCUT sample size with both genotype and gene expression data
was 882.
Gene ontology (GO) enrichment analysis was performed
including all genes that were differentially expressed with respect
to the inversion at a false discovery rate (fdr) <103. The analysis
was performed with GOstats bioconductor package. GO terms
were claimed as significantly associated with the inversion with
an FDR <0.05. A concept-network with GeneAnswers bio-
conductor package was then estimated.Statistical Analyses
Association analysis between phenotype and inversion genotype
was performed with the SNPassoc R package, which provides p
values from likelihood ratio test (LRT) as well as odds ratios (OR)
and 95% confidence intervals (95% CI) for different genetic
models (dominant, recessive, and additive).30 Multiple compari-
sons were addressed by correcting the p value for the exact number
of tests, that was considered as 2.2.31 Models were adjusted for
gender and the first two principal components to address popula-
tion stratification. Models for EGEA also considered family
structure.
FST values were calculated with the snpStats package v.1.8.1
from Bioconductor, and negative values were set to zero. To
construct the empirical null distribution, FST values were calcu-
lated in all HapMap 3 populations for both the inversion alleles
and a set of 1,024 chromosome 16 SNPs outside the inversion
and not in LD (r2 < 0.2). A null distribution of each pairwise com-
parison was generated with the respective p values.
Population stratification of inversion genotypes of HapMap
3 samples was assessed via multiple correspondence analysis.
Differential gene expression analysis between inversion genotypes
and genes was performed via generalized linearmodels and LRT by
means of the SNPassoc R package.30 LD (measured via R squaredrican Journal of Human Genetics 94, 361–372, March 6, 2014 363
Figure 1. Evidence of an Inversion Polymorphism Signal at 16p11.2
The figure shows the result of a sliding window scan with inveRsion in the 16p11.2 chromosomal region (28–30 Mb, hg18), with a
window size of 0.39 Mb in the CEU population. Segments with positive Bayesian Information Criterion (BIC) difference are considered
informative for the presence of LD differences in the population resulting from an inversion event. A schematic representation of the
genomic region with the blocks of segmental duplications as green filled rectangles is shown at the 0 value of the BIC difference. The
region includes the predicted inversion polymorphism (minimal single-copy interval between two blocks of segmental duplications)
and the limits of the detectable signal.statistic) between the inversion genotype and the SNPs in the re-
gion of interest was computed with snpStats.Results
Inversion Detection, Validation, and Comparative
Mapping
The experimental detection of inversions located in com-
plex genomic regions with large segmental duplications
is technically difficult. It usually relies on individually
applied cytogenetic, molecular cytogenetic, and more
recently paired-end sequencing methods. Nonetheless,
recently described and distinct methods such as Phase
Free Inversion Detection Operator (PFIDO), inveRsion,
and Principal Components Analysis (PCA) can infer inver-
sion polymorphism from SNP genotype data.20–22 These
methods mainly detect nonrecurrent inversions for which
recombination between the inverted and noninverted seg-
ments is suppressed in inversion heterozygotes. One such
detectable inversions is the ~0.45 Mb distal 16p11.2 inver-
sion.21 The inveRsion algorithm successfully detected sig-364 The American Journal of Human Genetics 94, 361–372, March 6nals of inversion in the interval between two blocks of
segmental duplications at chromosome band 16p11.2
(28.39–28.50Mb, hg18) (Figure 1).We used both inveRsion
and PFIDO approaches to detect and classify individual
chromosomes into the standard (EIFVar1/NI) or inverted
(EIFVar2/I) subpopulations (Table S1), initially using the
EGCUT (n ¼ 882) and the HapMap 3 (n ¼ 1,184) popula-
tions. A high calling concordance was observed between
PFIDO and inveRsion (0.96–0.97) (Table S1).
Comparative mapping of the human reference region
with the orthologous region in mouse and other mammals
revealed a redistribution of the human genome with
breaks of synteny at the positions where the human
segmental duplications have been generated. At least two
evolutionary chromosomal inversion events must have
occurred in the human reference chromosome with
respect to the ancestral allele (Figure 2).
BLAST alignment between the reference EIFVar1 and
inverted EIFVar2 sequences revealed 99.89% sequence
identity throughout the single-copy interval (119 Kb)
flanked by two large blocks of inverted paralogous
segmental duplications (134 Kb, 99.7% sequence identity), 2014
BA
Figure 2. Comparative Mapping, Gene Content, and Predicted Evolution of the Inversion Polymorphism at 16p11.2
(A) Comparative mapping of the human (HS) reference region with the orthologous region in mouse (MM) showing the gene content
and orientation according to the UCSC Genome Browser. The blue and red arrows with the connected lines illustrate the length and
relative orientation of the blocks of conserved synteny between both species. Genomic structure in other sequenced mammals, such
as cat, dog, and rat, is identical to that in mouse. Large and complex blocks of segmental duplications, absent in mouse, are observed
in the human map at the breaks of synteny.
(B) Schematic representation of the predicted evolutionary inversion between the mouse genome (MM) and the likely most ancestral
human allele (EIFVar2/I). The subsequent inversion between blocks of segmental duplications to generate the other allele (EIFVar1/
NI) in humans (HS) is shown at the bottom.
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Figure 3. Definition of Haplotype Markers, Experimental Validation, and Genotype Clustering
(A) Schematic representation of the EIFVar1/NI and EIFVar2/I alleles at 16p11.2 with the flanking segmental duplications (inverted dark
green arrows) and the single-copy interval in between. Other smaller blocks of segmental duplications are shown in light green. The
location of the two insertion-deletion polymorphisms and the specific alleles per haplotype are indicated.
(B) Results of genotyping by PCR these two indels in 14 HapMap individuals. Predicted inversion haplotypes of the same individuals by
inveRsion and PFIDO are shown on top of each line and represented in the plot below. An asterisk denotes the only individual with
discordant results.
(C) Plot showing the clustering of the different haplotypes predicted by PFIDO via multidimensional scaling (MDS) in some of the 1000
Genomes populations. Each circle (open for heterozygotes and filled for homozygotes) represents an individual from a population,
differentiated by colors as indicated. Abbreviations are as follows: ASW, African ancestry in Southwest USA; CEU, Utah residents with
Northern and Western European ancestry; CHB, Han Chinese in Beijing, China; CHD, Chinese in metropolitan Denver, Colorado;
MXL, Mexican ancestry in Los Angeles, California; JPT, Japanese in Tokyo, Japan; LWK, Luhya in Webuye, Kenya; TSI, Toscans in Italy;
YRI, Yoruba in Ibadan, Nigeria. The samples that have also been studied by PCR (Table S2) are represented by black circles, diamonds, or
triangles according their 19 bp indel genotype. A few samples also included in (B) are identified.(Figure 1). Interallelic sequence changes included multiple
SNPs, microsatellite length changes, and two small inser-
tion/deletion (indel) changes (Figure S1). We designed a
PCR-based method to genotype these two indel polymor-
phisms and correlated the results with the algorithm-based
inversion classification (Figure 3A). Out of 71 selected
HapMap individuals (142 chromosomes), a single non-
concordant chromosome was identified at the 19 bp
indel locus, reinforcing the accurate prediction of the
calling methods (99% concordance). High concordance
(90%) although with some more discrepancies (14 out of
136 chromosomes) was also found at the 27 bp indel.
These discrepancies are most probably due to the higher
mutation rate at this variable number of tandem repeat
locus, including a few chromosomes with a different allele
(Table S2). Additional haplotypes with structural and/or
sequence changes that cannot be currently resolved
appear to exist within the NI and I lineages, as noted
by the presence of six clearly distinguishable clusters by
a multidimensional scaling analysis of the SNPs in the366 The American Journal of Human Genetics 94, 361–372, March 6inverted region for the 1000 Genomes populations
(Figure 3B).
Inversion Origin and Population Distribution
We identified the genotypes at 24 representative SNPs on
strong LD (r2 > 0.8) with inversion haplotypes in the NI
and I alleles. At most of these loci, all nonhuman primates
as well as the Neandertal and Denisova genomes carry the
I-allele nucleotide (Table S3). Therefore, although the EIF-
Var1/NI is the most common allele in the human popula-
tions studied, comparative mapping data suggest that the I
allele is indeed themost ancient, and the allele represented
in the human reference genomemust have been generated
more recently in human evolution. Assuming a mutation
rate of 2.5 3 108, we estimated an ancient coalescence
of approximately 1.35 million years ago.
The I-allele frequency ranged from 0.10 in Eastern Afri-
cans (Massai from Kenya) to 0.49 in Northern Europeans
(Estonia), showing significant stratification in HapMap 3
populations (Figure 4, Table S4). Allele frequencies were, 2014
Figure 4. Worldwide Population Stratifi-
cation of 16p11.2 Inversion
(A) Frequency of ~0.45 Mb 16p11.2 inver-
sion alleles in different populations, with
the circles located on the map at their
approximate geographic origin. The figure
shows very low frequencies of the I allele
in Africa and Asia populations and gradual
increase in European populations with
higher frequencies in the north.
(B) The two principal components obtained
after performing a correspondence analysis
via inversion polymorphism genotypes
of HapMap 3 samples are represented. Pre-
valence of the inversion clusters changes
according to the geographical popula-
tion origin, indicating strong population
stratification.
The populations included in the analysis are
the following: ASW (n¼ 83); CEU (n¼ 165);
CHB (n ¼ 84); CHD (n ¼ 85); JPT (n ¼ 86);
LWK (n ¼ 90); MXL (n ¼ 77); TSI (n ¼ 88);
YRI (n ¼ 167); MKK, Massai in Kinyawa,
Kenya (n ¼ 171); GIH, Gujarati Indians in
Houston, Texas (n ¼ 88); SPA, Spaniards in
Spain (n ¼ 765); EST, Estonian in Estonia
(n ¼ 882).found at Hardy-Weinberg equilibrium in each population,
except for the Gujarati Indians in Houston, using a rela-
tively conservative threshold for equilibrium rejection
(p < 0.05) (Table S4). The distribution of frequencies
showed a systematic gradation over space. However, the
inversion distribution does not appear to correlate with
demographic factors because pairwise FST values did not
fully correlate with the geographic distance between
sampled populations (Figure S2). Therefore, these data
highly indicate either a remarkable drift or signatures of
selection for the inversion alleles in different populations.
Association with the Joint Occurrence of Asthma
and Obesity
A decreased risk of asthma associated with the I allele was
found in the ECRHS-I data set (333 asthma cases and 1,527
controls), borderline significant under a dominant model
(OR ¼ 0.75, 95% CI ¼ 0.59–0.96, p ¼ 0.0231, corrected
p ¼ 0.0508) (Table S5). This risk was further and signifi-
cantly decreased for the joint occurrence of asthma and
obesity also under a dominant model (OR ¼ 0.35, 95%
CI ¼ 0.14–0.84, p ¼ 0.0178, corrected p ¼ 0.039). The
additive model was also borderline significant (OR ¼
0.40, p ¼ 0.0379, corrected p ¼ 0.0834) whereas recessive
was not (p ¼ 0.1410).
Given that dominant was the best model of inheritance,
it was selected for replication in four additional inde-
pendent studies. A protection for the asthma and obesity
co-occurrence with the I haplotype was also found inThe American Journal of Humaneach study (OR ¼ 0.33–0.62). A meta-
analysis of the results of the five studies
improved the significant evidence for adecreased risk of asthma in obese people with the I allele
(OR¼ 0.48, 95% CI ¼ 0.34–0.66, p ¼ 5.53 106) (Figure 5,
Table S5). The estimated population attributable risk of the
inversion polymorphism for the asthma and obesity
phenotype was 39.7%. The association of the I allele
with asthma alone in themeta-analysis was also significant
but weaker (OR ¼ 0.82, 95% CI ¼ 0.73–0.93, p ¼ 0.0026)
(Figure S4), whereas there was no significant association
between the inversion polymorphism and obesity in non-
asthmatic subjects (Table S5).
We then investigated whether a set of SNPs can tag the
inversion polymorphism by computing LD between the
inversion and the SNPs of the region. We observed clusters
of high LD composed of 7 SNPs in a small 30 Kb interval
within the inversion (28.42–28.45 Mb) (r2 > 0.8) and
24 SNPs in a 70 Kb region (28.73–28.8 Mb) immediately
proximal to the inversion with r2 > 0.94 (Figure 6A).
Interestingly, SNP rs26528 is within the IL27 locus and
rs7498665 in SH2B1. The search for independent associa-
tion of SNPs in the region with either the asthma or BMI
variables did not yield significant results in any of the stud-
ied sample data sets, indicating that the observed effect on
asthma and obesity is more probably due to the entire
inversion haplotype or a combination of SNPs than to
individual SNPs.
Functional Characterization
In order to characterize the functional consequences of
the inversion polymorphism and define candidate genesGenetics 94, 361–372, March 6, 2014 367
Figure 5. Meta-analysis Forest Plot for the Association Studies of Inversion with Phenotypes
The results of the association analysis between the ~0.45 Mb 16p11.2 distal inversion with asthma, stratified by obesity phenotype
(BMI R 30 kg/m2) in the five independent studies are shown. The inversion-allele effect (IE), the standard error of the effect (sIE),
the odds ratio (OR) with confidence intervals, and the relative weight (W) of each study correspond to the inversion allele effects under
a dominant model on asthma in obese individuals.for the associated phenotypes, we analyzed gene expres-
sion levels in peripheral blood of EGCUT and lymphoblas-
toid cell lines of HapMap CEU samples (Figure 6B). Several
genes located in the chr16 inversion or immediately flank-
ing intervals were identified in both data sets among the
top ten most differentially expressed genes per inversion
genotype (Table 1). In particular, expression of TUFM
(mitochondrial Tu translation elongation factor [MIM
602389]), SULT1A4 (sulfotransferase family, cytosolic, 1A,
phenol-preferring, member 4), SPNS1 (spinster homolog
1 [MIM 612583]), SULT1A1 (sulfotransferase family, cyto-
solic, 1A, phenol-preferring, member 1 [MIM 171150]),
and CCDC101 (coiled-coil domain containing 101 [MIM
613374]) highly correlated with the inversion genotypes
(p ranging from 1040 to 107) in EGCUT (Table S5). In
the HapMap CEU samples, SNPS1, EIF3C (eukaryotic trans-
lation initiation factor 3, subunit C [MIM 603916]), and
TUFM were also among the most differentially expressed
genes (p < 1 3 102), and IL27 expression also showed
some correlation with the inversion (p¼ 1.03 102) (Table
S6). Expression effects were observed on single-copy genes
located within the inversion (IL27 and CCDC101) and
immediately proximal interval (TUFM and SPNS1), as
well as on multiple-copy genes located in the flanking
segmental duplications (EIF3C, SULT1A1, and SULT1A4).
In the case of TUFM, SPNS1, EIF3C, SULT1A1, and
APOB48R, expression levels were higher in I alleles; for
SULT1A4 and CCDC101, expression levels were higher in
NI alleles; and in the case of IL27, the higher expression
was in NI/I heterozygotes (Figures S4–S8 and Tables S6,
S7 and S8).
We then estimated the percentage of observed variability
in gene expression of the top five genes explained by the
inversion genotype, gender, and BMI in EGCUT samples.
We observed that in all five genes, the inversion is the
factor explaining the highest percentage of variability,
ranging from 3.1% (CCDC101) to 17% (TUFM) (Table
S9). Therefore, the expression variation of these genes is
most likely related to the inversion itself, driven either by
direct mechanisms such as chromatin structure or posi-
tional change of promoter or enhancer elements or by368 The American Journal of Human Genetics 94, 361–372, March 6indirect effects secondary to functional SNPs fixed on the
different haplotypes with no recombination.
In order to define in amore globalway the transcriptomic
effects of the 16p11.2 inversion, gene ontology (GO)
enrichment analysis was performed including all genes
differentially expressed in both data sets with respect to
the inversion (p < 103). A concept-network was obtained
with remarkable enrichment of terms related to regulation
and activation of immune response, positive regulation of
leukocyte, lymphocyte, and Tcell activation, NK-Tcell pro-
liferation, and immune response to virus, as well as regu-
lation of response to stress and biotic stimulus (Figure S9).Discussion
We report here that the ~0.45 Mb 16p11.2 inversion is a
common polymorphism that can be efficiently inferred
from SNP data in different populations as a result of the
inversion-mediated suppression of recombination. This
also indicates that its origin is ancient with very low recur-
rence, similar to other reported genomic inversions that
can be tagged by SNP haplotypes.20,32 However, the classi-
fication is not perfect as noted by the presence of distin-
guishable clusters in the different populations, which are
probably due to additional structural or sequence changes
within and/or in the flanking regions not yet resolved
(Figure 3C). The inversion contains a single-copy inverted
interval (119 Kb) flanked by two large blocks of highly
similar segmental duplications that most likely mediated
the evolutionary inversion by nonhomologous unequal
recombination. This complex structure precludes the gen-
otyping of the inverted alleles by standardmethods such as
interphase FISH, long PCR, or paired-end mapping by
sequencing, even via large insert clones. Therefore, the
experimental validation of the predicted inversion geno-
types or haplotypes was achieved by using an indel poly-
morphism that almost perfectly tagged both the I and NI
alleles. This marker can also be used for high-scale geno-
typing in other populations when SNP data from the re-
gion are not available., 2014
Figure 6. Functional Correlations of the 16p11.2 Inversion
(A) LD between the ~0.45 Mb 16p11.2 inversion polymorphism and SNPs in the 28.2–29.5 Mb region of chromosome 16. Gene anno-
tation was taken from the UCSC Genome Browser, hg18 assembly. IL27 and SH2B1 are highlighted in blue and red, respectively, and by
vertical shading, indicating they have been already reported as asthma and obesity susceptibility genes, respectively, by association
studies.
(B) Quantile-quantile plot of genes corresponding to gene expression analysis in the Estonian samples.
(C) Barplot showing the top five gene ontology (GO) category distribution of the genes differentially expressed (FDR< 103) with respect
to the inversion in Estonian samples.Contrary to expected, comparative mapping indicated
that the I allele is more ancient and the reference and
most common allele in all populations studied must
have been generated more recently in human evolution.
However, I allele frequencies were very low in Africans
and eastern Asians, being higher in Europeans with a
gradation increasing from south to north. The poor corre-
lation of allelic frequencies with the demographic history
of the human populations suggests either an extraordinary
genetic drift or, most likely, selective sweeps for the
16p11.2 inversion alleles. When the NI allele appeared in
humans around 1.35 million years ago, it might have pro-
vided a strong fitness bonus in order to become the most
common over time in Africa. However, after themigrations
out of Africa 50,000 to 100,000 years ago, the I allele may
have provided its own advantage mainly to the popula-
tions migrating farther north in Europe. A similar pattern
of population stratification with African origin and
remarkable genetic drift or selective sweeps has been re-
ported for the 17q21.31 inversion polymorphism.32
We found a strong correlation of inversion genotypes
with expression effects on several regional genes. TheseThe Ameexpression effects in cis could be driven either by direct
mechanisms, such as chromatin structure or positional
change of promoter or enhancer elements, or by indirect
effects secondary to functional SNPs fixed on the different
inversion haplotypes with no recombination. In agree-
ment with our data, a cluster of five SNPs of the region
has been previously associated with the expression of
CLN3 (ceroid-lipofuscinosis, neuronal 3 [MIM 607042]),
and three SNPs at SH2B1 were associated with EIF3C and
TUFM levels in lymphocytes.33 In addition, a single SNP
(rs7498665) in strong LD with inversion alleles was highly
correlated with the expression of several genes (TUFM,
SULT1A1, SULT1A2, SH2B1, APOB48R, and EIF3C) in blood
and/or adipose tissue of the Icelandic population.8 Given
that all these SNPs are in strong LD with inversion alleles,
some relevant changes on gene expression are probably
due to indirect effects of the maintenance of allelic combi-
nation influencing levels of several transcripts, although
direct effects of the inversion can not be discarded.
The I allele of the 16p11.2 inversion has a significant
protective effect on the risk of asthma, stronger for the
co-occurrence of asthma and obesity, as documented inrican Journal of Human Genetics 94, 361–372, March 6, 2014 369
Table 1. Top Five Deregulated Genes of the Chromosome 16 in Association with 16p11.2 Inversion Alleles
Probe Set p Value Start (bp) End (bp) Gene NI/NI NI/I I/I
ILMN_1738369 3.0 3 1040 28,761,849 28,761,898 TUFM  ref þ
ILMN_2336133 7.8 3 1031 29,467,127 29,476,300 SULT1A4 þ ref 
ILMN_1681016 4.2 3 1013 28,903,301 28,903,350 SPNS1  ref þ
ILMN_1657302 1.8 3 107 28,538,926 28,538,955 SULT1A1  ref þ
ILMN_1684789 2.2 3 107 28,510,516 28,510,565 CCDC101 þ ref 
Annotation taken from UCSC Genome Browser, hg18 assembly. Columns NI/NI, NI/I, I/I provide information about the mean value of gene expression of each
genotype with respect to the heterozygous NI/I, provided as reference. Plus sign (þ) indicates more; minus sign () indicates less.five independent studies. It could also read in the opposite
direction, implying that the most common NI allele con-
tributes to the susceptibility for the joint occurrence of
asthma and obesity. Remarkably, this inversion polymor-
phism accounts for 3% of the shared components of
variance between asthma and obesity with a population
attributable risk of 39.7%, thus representing a large propor-
tion of the estimated 8% of variance explained by genetic
factors.6 The influence of the inversion on this shared
susceptibility is probably mediated by its proven strong
effect on the expression of several neighboring genes
with regulatory functions of both energy balance, such
as APOB48R, SH2B1, and TUFM, and immunity, such as
IL27 and also TUFM.
APOB48R encodes the apolipoprotein B48 macrophage
receptor that binds to the apolipoprotein B48 of dietary tri-
glyceride-rich lipoproteins and provides essential lipids,
lipid-soluble vitamins, and other nutrients to reticuloen-
dothelial cells. Dietary fat induces lipid accumulation
along with APOB48R transcription in circulating mono-
cytes.34 Variations close to or in the SH2B1 have been
found to associate with obesity in two very large
GWASs,7,8 but the risk of obesity is conferred by the
SH2B1 variant in LD with the I allele, which is protective
for the association of asthma and obesity in our data.
TUFM, whose recessive mutations cause combined oxida-
tive phosphorylation deficiency (MIM 610678) resulting
in lactic acidosis and fatal encephalopathy, participates
in protein translation in mitochondria as well as in the
regulation of type 1 interferon and autophagy attenuating
the inflammatory response to infections.35 In further
agreement with a potential role of these last two genes in
the regulation of energy balance, TUFM has been found
upregulated in adipose tissue, muscle, and liver, and
SH2B1 was upregulated in muscle and downregulated in
hypothalamus of Long-Evans rats fed on high-fat diet.36
IL27 is one of the critical cytokines that mediates be-
tween the innate and adaptive immune system. IL27
downregulates airway hyperreactivity and lung inflam-
mation during the development of allergic asthma
through its suppressive effect on cytokine production.
IL27 also cooperates with IFN-g to inhibit glucocorticoid-
induced translocation of the glucocorticoid receptor to
the nucleus of macrophages inducing glucocorticoid-resis-370 The American Journal of Human Genetics 94, 361–372, March 6tant airway hyperresponsiveness in a mouse model.37
Expression of IL27 and IFN-g is increased in the induced
sputum of steroid-refractory asthmatics. Inflammation
and airway hyperresponsiveness are hallmark features
of asthma and deficient type I interferon induction has
been reported in atopic asthma exacerbations.38 Therefore,
deregulation of IL27 and impaired interferon induction
mediated by TUFM with secondary dysfunction of the
innate host defense pathways might underlie the higher
susceptibility to severe, and possibly steroid-refractory,
asthma associated with obesity in NI-allele carriers.
Evidence for adaptive elevations in basal metabolic rate
has been reported in northern (circumpolar) popula-
tions.39 Given the positive selection of I alleles with an
apparent south to north gradient in Europeans and the
remarkable contribution to TUFM expression (explaining
17% of gene expression variability), improved mitochon-
drial function and basal energy balance associated with
higherTUFMexpressionof the I allelesmighthaveconferred
an adaptive advantage to the cold climate for the northern
populations. This potential selection signature is in line
with the pattern of selection of the human mitochondrial
DNA and other genes of mitochondrial function.40 In addi-
tion, it has been shown that overexpression of TUFM can
rescue mutated mitochondrial tRNAs from degradation,
acting as suppressor of mitochondrial defects.41,42 This is
another potential contributor mechanism to positive selec-
tion because it is becoming evident that somatic mutations
in human mitochondrial tRNA genes are associated with
degenerative disorders, aging, and cancer.43
The analysis of all genes differentially expressed with
respect to the inversion also revealed a remarkable enrich-
ment of terms related to regulation and activation of im-
mune response, response to stress, and biotic stimulus.
This pattern is consistent with a disturbance of immune
response and energy metabolism and further support the
observation that genes deregulated by the inversion poly-
morphism or associated haplotypes may be responsible
for the joint protection against asthma and obesity, along
with potentially conferring divergent adaptive advantages
to different climates.
In summary, by affecting gene expression, the 16p11.2
inversion polymorphism provides a shared genetic basis
for the joint susceptibility to asthma and obesity, with, 2014
uneven distribution in different world populations result-
ing fromeither extraordinary genetic drift or adaptive selec-
tion. Our data reinforce the concept that the association of
asthma and obesity share some common genetic basis as
part of their multifactorial etiology, providing additional
clues to understand the shared physiopathology and guide
specific therapies. The ~0.45 Mb 16p11.2 inversion joins
other genomic inversions also associated with disease
susceptibility that can be tagged by SNP haplotypes.20,44
Becausegenome-widegenomic inversionshavebeenpoorly
explored to date, additional studies to better define their fre-
quency, evolutionary history, and potential contribution to
human genetic variation and disease are required.Supplemental Data
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